Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ISPR
ISPR logo

ISPR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.885
Open
1.760
VWAP
1.79
Vol
103.18K
Mkt Cap
103.89M
Low
1.670
Amount
184.52K
EV/EBITDA(TTM)
--
Total Shares
57.40M
EV
85.80M
EV/OCF(TTM)
57.16
P/S(TTM)
1.15
Ispire Technology Inc. is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded and non-branded e-cigarettes and vaping hardware products in both the nicotine and cannabis spaces. The Company’s nicotine products are marketed under the Aspire brand name, primarily through a global distribution network. It sells its cannabis vaping hardware in the United States, Canada, South Africa, and Germany. Its cannabis products are marketed under the Ispire brand name, primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies, including multi- and single-state operators, brand owners, and co-packers. Its product portfolio includes E-Cigarette Products and Cannabis Products. The Company's open system devices are marketed under brands such as Nautilus and Zestquest and closed system products are marketed under licensed brands including BRKFST and Hidden Hills Club.
Show More

Events Timeline

(ET)
2026-05-12
08:40:00
Ispire Forms Joint Venture with Shandong Jincheng Pharma
select
2026-05-07 (ET)
2026-05-07
07:50:00
Ispire Reports Q3 Revenue of $18.7M
select
2026-03-16 (ET)
2026-03-16
08:10:00
Ispire Technology Says FDA Guidance Unlocks $50 Billion Market Opportunity
select
2026-02-06 (ET)
2026-02-06
07:10:00
Ispire Reports Q2 Revenue of $20.3M
select
2025-06-09 (ET)
2025-06-09
16:33:31
Ispire Technology subsidiary reaffirms full compliance with Malaysian laws
select
2025-05-22 (ET)
2025-05-22
09:02:19
Ispire Technology approved for nicotine product manufacturing in Malaysia
select
2025-05-15 (ET)
2025-05-15
16:32:52
Ispire Technology names Jay Yu as CFO, reduces workforce
select
2025-05-01 (ET)
2025-05-01
08:39:31
Ispire Technology files application with FDA for age-verification component
select
2025-02-10 (ET)
2025-02-10
06:14:43
Ispire Technology reports Q2 EPS (14c) vs. (7c) last year
select

News

NASDAQ.COM
2.0
05-28NASDAQ.COM
Railroad Stocks Underperform on Thursday
  • Sector Decline: Railroad stocks collectively fell by approximately 1.5% on Thursday, indicating a weakening market confidence in the sector, which could negatively impact investor expectations for future earnings.
  • Norfolk Southern Underperformance: Norfolk Southern's shares dropped by about 4.8%, making it the worst performer in the industry, suggesting potential operational or market challenges facing the company.
  • Union Pacific Decline: Union Pacific's stock fell by around 4%, further exacerbating the overall weakness in the railroad sector, which may lead investors to reassess their investment strategies.
  • Market Sentiment Impact: The decline in railroad stocks contrasts with broader market trends, potentially raising concerns about economic slowdown and affecting investment inflows into related industries.
PRnewswire
7.5
05-12PRnewswire
Ispire Partners with Jincheng Pharma to Enter Growing Nicotine Market
  • Strategic Partnership: Ispire has formed a joint venture with Jincheng Pharma to manufacture and commercialize nicotine pouch products, marking Ispire's entry into the rapidly growing oral nicotine market, which is projected to exceed $40 billion by 2033, significantly broadening the company's product portfolio.
  • Market Potential: According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is expected to grow at nearly 25% annually, providing Ispire with substantial market opportunities to quickly establish a new revenue stream.
  • Enhanced Production Capacity: Jincheng Pharma will contribute manufacturing equipment and technical expertise to support Ispire's rapid production ramp-up, and by leveraging Ispire's strengths in precision dosing and global distribution, the partnership aims to enhance product differentiation in a competitive market.
  • Global Expansion: This collaboration not only strengthens Ispire's manufacturing capabilities but also utilizes Jincheng Pharma's customer relationships and pharmaceutical expertise to ensure the rapid production of high-quality nicotine pouches, further advancing Ispire's development within its international nicotine platform strategy.
Newsfilter
7.5
05-12Newsfilter
Ispire Forms Joint Venture with Jincheng Pharma for Nicotine Pouches
  • Market Expansion: Ispire's joint venture with Jincheng Pharma marks its entry into the rapidly growing oral nicotine market, projected to exceed $40 billion by 2033, significantly broadening Ispire's product portfolio beyond vaping hardware.
  • Production Capacity Boost: The joint venture will leverage Jincheng Pharma's pharmaceutical equipment and technical expertise to rapidly scale nicotine pouch production, enabling swift commercialization and enhancing Ispire's position in a competitive market.
  • Strategic Collaboration: This partnership combines Ispire's strengths in precision dosing and global distribution, expected to create new revenue streams and advance its broader nicotine platform strategy.
  • Industry Leadership: Jincheng Pharma selected Ispire as a partner due to its reputation for high-quality manufacturing and robust global compliance capabilities, indicating that Ispire's leadership in the global nicotine market will be further solidified.
seekingalpha
9.5
05-08seekingalpha
Ispire Technology Q3 2026 Earnings Call Insights
  • Financial Performance Overview: Ispire reported revenue of $18.7 million for Q3 2026, down from $26.2 million in Q3 2025, primarily due to seasonal factory downtime during the Chinese New Year, reflecting the company's resilience amid market fluctuations.
  • Cash Flow Status: The company ended the quarter with $18 million in cash, an increase of $468,000 sequentially, reinforcing management's confidence in achieving cash flow positivity in the second half of 2026, indicating a steady recovery towards profitability.
  • Malaysia Manufacturing Platform: Ispire's Malaysia manufacturing platform is now operational, expected to provide a 25% tariff advantage, enhancing the company's competitiveness in the $73 billion global vape market and laying the groundwork for future customer acquisition and margin improvement.
  • Vapor ODM Initiative: Plans are underway to launch the Vapor ODM initiative in July, initially targeting small and mid-sized brands with larger brand opportunities anticipated for 2027, showcasing the company's strategic positioning in market segmentation and product innovation.
seekingalpha
9.5
05-07seekingalpha
Ispire Technology Reports Q3 Earnings with Revenue Decline
  • Earnings Performance: Ispire Technology reported a Q3 GAAP EPS of -$0.17 with revenue of $18.7 million, reflecting a significant year-over-year decline of 28.6%, indicating pressure in market competition and challenges in profitability.
  • Cash Flow Status: As of March 31, 2026, the company held $18 million in cash and only $0.9 million in working capital, suggesting difficulties in cash flow management that could impact future operations and investment capabilities.
  • FDA Approval Progress: Ispire Technology is currently awaiting FDA approval, a critical milestone that will directly affect the timing of product launches and market competitiveness; if approved, it could open new revenue streams for the company.
  • Market Reaction: Due to the poor financial performance, investor confidence in Ispire Technology has been shaken, potentially leading to further downward pressure on the stock price, which may affect the company's future financing and strategic development.
PRnewswire
9.5
05-01PRnewswire
Ispire Technology to Host Earnings Call on May 7, 2026
  • Earnings Call Announcement: Ispire Technology will host an earnings conference call on May 7, 2026, at 8:00 am ET to discuss its financial results for the third quarter ended March 31, 2026, aiming to provide investors with insights into its latest financial performance and future outlook.
  • Participation Details: Participants can dial in using the provided numbers and request the “Ispire Technology Call” to listen to the meeting, and the call will also be webcast live, ensuring that all interested parties can access real-time information.
  • Playback Information: After the call, a playback will be available by dialing 1-844-512-2921 or 1-412-317-6671 with passcode 10208863, and this service will be available until 11:59 pm ET on May 21, 2026, allowing investors who missed the live event to catch up.
  • Company Overview: Ispire Technology focuses on the research, development, and sales of e-cigarettes and cannabis vaping products, holding over 400 patents globally, with its branded products sold worldwide, showcasing its strong competitive position and market influence in the industry.
Wall Street analysts forecast ISPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast ISPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
6.50
Averages
6.50
High
6.50
Current: 0.000
sliders
Low
6.50
Averages
6.50
High
6.50
No data

No data

Valuation Metrics

The current forward P/E ratio for Ispire Technology Inc (ISPR.O) is 0.00, compared to its 5-year average forward P/E of -9.88. For a more detailed relative valuation and DCF analysis to assess Ispire Technology Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.88
Current PE
0.00
Overvalued PE
188.60
Undervalued PE
-208.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-21.89
Current EV/EBITDA
-12.63
Overvalued EV/EBITDA
8.24
Undervalued EV/EBITDA
-52.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.54
Current PS
0.91
Overvalued PS
2.44
Undervalued PS
0.64

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

any other good options to consider
Intellectia · 41 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Analyst Consensus: Moderate Buy, Strong BuyRelative Vol: >= 1.50Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
SES logo
SES
SES AI Corp
861.57M
LAES logo
LAES
Sealsq Corp
830.10M
GAU logo
GAU
Galiano Gold Inc
745.60M
UROY logo
UROY
Uranium Royalty Corp
655.79M
EU logo
EU
enCore Energy Corp
610.54M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
penny stocks to buy tomorrow
Intellectia · 20 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Relative Vol: >= 1.50Earnings Surprise: EpsBeatWeek Price Change Pct: >= $3.00
Ticker
Name
Market Cap$
top bottom
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
INN logo
INN
Summit Hotel Properties Inc
526.61M
ACTG logo
ACTG
Acacia Research Corp
385.84M
AUNA logo
AUNA
Auna SA
364.88M
GLDG logo
GLDG
GoldMining Inc
344.04M
TYGO logo
TYGO
Tigo Energy Inc
243.42M
Show bullish stocks value between $1 to $4
Intellectia · 12 candidates
Price: $1.00 - $4.00Relative Vol: >= 1.50Rsi 14: 65 - 70Moving Average Relationship: PriceAboveMA20Month Price Change Pct: >= $10.00
Ticker
Name
Market Cap$
top bottom
BBD logo
BBD
Banco Bradesco SA
39.45B
EU logo
EU
enCore Energy Corp
610.54M
TRUE logo
TRUE
TrueCar Inc
225.91M
SRG logo
SRG
Seritage Growth Properties
215.16M
ISPR logo
ISPR
Ispire Technology Inc
191.35M
ONCY logo
ONCY
Oncolytics Biotech Inc
125.90M

Whales Holding ISPR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ispire Technology Inc (ISPR) stock price today?

The current price of ISPR is 1.81 USD — it has increased 1.12

What is Ispire Technology Inc (ISPR)'s business?

Ispire Technology Inc. is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded and non-branded e-cigarettes and vaping hardware products in both the nicotine and cannabis spaces. The Company’s nicotine products are marketed under the Aspire brand name, primarily through a global distribution network. It sells its cannabis vaping hardware in the United States, Canada, South Africa, and Germany. Its cannabis products are marketed under the Ispire brand name, primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies, including multi- and single-state operators, brand owners, and co-packers. Its product portfolio includes E-Cigarette Products and Cannabis Products. The Company's open system devices are marketed under brands such as Nautilus and Zestquest and closed system products are marketed under licensed brands including BRKFST and Hidden Hills Club.

What is the price predicton of ISPR Stock?

Wall Street analysts forecast ISPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPR is6.50 USD with a low forecast of 6.50 USD and a high forecast of 6.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ispire Technology Inc (ISPR)'s revenue for the last quarter?

Ispire Technology Inc revenue for the last quarter amounts to 18.69M USD, decreased -28.66

What is Ispire Technology Inc (ISPR)'s earnings per share (EPS) for the last quarter?

Ispire Technology Inc. EPS for the last quarter amounts to -0.17 USD, decreased -10.53

How many employees does Ispire Technology Inc (ISPR). have?

Ispire Technology Inc (ISPR) has 81 emplpoyees as of May 31 2026.

What is Ispire Technology Inc (ISPR) market cap?

Today ISPR has the market capitalization of 103.89M USD.